Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force
Збережено в:
| Опубліковано в: : | Experimental Oncology |
|---|---|
| Дата: | 2006 |
| Автори: | , , , , , , , , , , , , , , , , |
| Формат: | Стаття |
| Мова: | Англійська |
| Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2006
|
| Теми: | |
| Онлайн доступ: | https://nasplib.isofts.kiev.ua/handle/123456789/137577 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force / D. Mauri, K. Kamposioras, N.P. Polyzos, Flores F.J. Rivas, H. Altinoz, M. Chojnacka, I. Karentzou, M. Dambrosio, C. Colichi, T. Oxiuzova, E. Kanavoura, Sousa B.A.M. da Silva Alves de, D. Ivanova, J. Mauri, V. Karampoiki, A. Maragkaki, 
 A. Xilomenos // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 252-253. — Бібліогр.: 12 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| _version_ | 1860211049344532480 |
|---|---|
| author | Mauri, D. Kamposioras, K. Polyzos, N.P. Flores F.J. Rivas Altinoz, H. Chojnacka, M. Karentzou, I. Dambrosio, M. Colichi, C. Oxiuzova, T. Kanavoura, E. Sousa B.A.M. da Silva Alves de Ivanova, D. Mauri, J. Karampoiki, V. Maragkaki, A. Xilomenos, A. |
| author_facet | Mauri, D. Kamposioras, K. Polyzos, N.P. Flores F.J. Rivas Altinoz, H. Chojnacka, M. Karentzou, I. Dambrosio, M. Colichi, C. Oxiuzova, T. Kanavoura, E. Sousa B.A.M. da Silva Alves de Ivanova, D. Mauri, J. Karampoiki, V. Maragkaki, A. Xilomenos, A. |
| citation_txt | Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force / D. Mauri, K. Kamposioras, N.P. Polyzos, Flores F.J. Rivas, H. Altinoz, M. Chojnacka, I. Karentzou, M. Dambrosio, C. Colichi, T. Oxiuzova, E. Kanavoura, Sousa B.A.M. da Silva Alves de, D. Ivanova, J. Mauri, V. Karampoiki, A. Maragkaki, 
 A. Xilomenos // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 252-253. — Бібліогр.: 12 назв. — англ. |
| collection | DSpace DC |
| container_title | Experimental Oncology |
| first_indexed | 2025-12-07T18:14:35Z |
| format | Article |
| fulltext |
252 Experimental Oncology 28, 252–253, 2006 (September)
Major advances in anticancer medical therapies
have been performed in last decades, and the poten-
tial impact on survival of the new chemotherapeutical,
anti-angiogenic and biological molecules had been
clearly discussed in literature.
Despite the availability of new therapeutical agents
is quite homogeneous among the two continents,
comparison of SEERS and EUROCARE databases
evidenced US vs. European cancer survival advan-
tages, particularly when colorectal malignancies were
considered [1, 2]. Correction for stage at diagnosis
consistently reduced colorectal survival differences
and the reduction was substantially unrelated to the
European geographic area analyzed, thus confirm-
ing that treatment modalities may be almost uniform
between the two continents.
Since early diagnostic procedures might be much
less available in Europe than in USA [1], the presence
of a diagnostic screening-related bias was hypo-
thesized to explain the observed survival difference.
Deficiencies in European cancer screening guideline
implementation and inadequacy of screening test
advising in primary care setting have been highlighted
in literature [3–9].
Monitoring of early diagnostic procedures is con-
sequently required in order to tailor a comprehensive
European health-policy planning.
Furthermore, the European health sanitary systems
are not homogeneous due to the different economic
backgrounds and the different languages spoken in
each nation. In order to bridge the European cancer
screening experiences in a comprehensive standardi-
zed survey of screening patterns an international task
force was developed. All network and project planning
was directed from the PACMeR of Athens (Pan-Hellenic
Association for Continual Medical Research), and at
present it involves 14 centers in 9 European Nations.
In 2004 the group presented preliminary results:
SESy_Europe database (Screening Evaluation Sys-
tem — Europe) [10, 11] a multilanguage 3-components
database dedicated to cancer screening monitoring
among European countries.
Database is focused on major “malignant killers” and
preventable malignancies (breast, cervical, colorectal,
lung, urinary tract, skin and prostate cancer early-de-
tection practices) and targeted to the analysis of both
cost-effective (e.g. mammography, Papanicolaou
smear, stool occult blood test) and not-recommended
procedures (e.g. full chest radiography, urinalysis).
Table. Actual profile of Sesy Europe Database: analyzed variables orga-
nized by category (socio-demographic elements, cancer related risk fac-
tors, over-practice patterns, practice patterns); standardized translation in
10 languages; PHE — Periodic Health Examination
SESy_Europe Database profile
Sociode-
mographic
elements
Age and gender
Education
Family status
Profession
Provenance
Urban area
Personal
risks
Body mass index
Cancer family history
Disease history Gynecologi-
cal profile Height and weight
Insurance coverage
PHE rate
Solitude
Skin type
Behavioral
risk fac-
tors
Alcohol
Diet
Sun exposure
Tobacco
Screening
over-
practice
patterns
Blood count
Chest X-Rays
Prostate cancer
Urinalysis
Screening
practice
patterns
Breast cancer
Cervical cancer
Colorectal cancer
Skin Cancer
Languages o Bulgarian
o English
o French
o German
o Greek
o Italian
o Polish
o Romanian
o Russian
o Spanish
o Turkish
Rethinking anticanceR scReening stRategies saving lives
at fRont line. Results fRom sesy_euRope task foRce
D. Mauri1, K. Kamposioras1, N.P. Polyzos1, F.J. Rivas Flores2, H. Altinoz3, M. Chojnacka4, I. Karentzou5,
M. Dambrosio6, C. Colichi7, T. Oxiuzova8, E. Kanavoura8, B.A.M. da Silva Alves de Sousa9, D. Ivanova1,
J. Mauri10, V. Karampoiki1, A. Maragkaki1, A. Xilomenos1
1PACMeR sections of Oncology, Dermatology and Public Health, Athens, Greece
2San Rafael Hospital, Clinic Documentation, Madrid, Spain
3SSK Sureyyapasa, Thoracic Disease Center, Istanbul, Turkey
4Maria Sklodowska-Curie Memorial Cancer Center, Department of Radiation Oncology, Warsaw, Poland
5Cologne University, School of Medicine, Cologne, Germany
6Multimedica Hospital, Department of Oncology, Milan, Italy
7Department of Medical Oncology, Institute of Oncology, Bucharest, Romania
8Ioannina School of Medicine, Ioannina, Greece
9Department of Medical Oncology, Portuguese Oncology Institute (IPOPFG-EPE), Porto, Portugal
10PACMeR, Engineering and Development section, Milan, Italy
Received: July 19, 2006.
*Correspondence: E-mail: pacmer_science@yahoo.com
Abbreviations used: EUROCHIP — European Cancer Health Indi-
cator Project; PACMeR — Pan-Hellenic Association for Continual
Medical Research; SESy_Europe database — Screening Evaluation
System — Europe; PHE — periodic health examination.
Exp Oncol 2006
28, 3, 252–253
letteR to editoR
Experimental Oncology 28, 252–253, 2006 (September) 253
Software has already been tested in Greece for its
feasibility in recording and data storing. A nationwide
sample of more than 6.500 Hellenic individuals had
been registered in the database and related data will
be soon released to medical literature. Standardized
pre-codified translations (ID-related) of 2,331 parame-
ters had been adjourned for all the basic eight lan-
guages of the database, and translation in Bulgarian,
Polish and Russian has been added. The database
had been proposed to the Steering Committee of the
EUROCHIP (European Cancer Health Indicator Pro-
ject) [12] and it is under evaluation for its application
in the wider Europe (since the Panhellenic Associa-
tion for Continual Medical Research PACMeR-ΠΕΔΙΕ
is a non-profit medical association, the database will
be provided free of charge). The actual profile of the
database is presented in the table.
RefeRences
1. Gatta G, Ciccolallo L, Capocaccia R, Coleman MP,
Hakulinen T, Moller H, Berrino F, Eurocare working group.
Differences in colorectal cancer survival between European
and US populations: the importance of sub-site and morpholo-
gy. Eur J Cancer 2003; 39: 2214–22.
2. Gatta G, Capocaccia R, Coleman MP, Gloeckler
Ries LA, Hakulinen T, Micheli A, Sant M, Verdecchia A,
Berrino F. Toward a comparison of survival in American and
European cancer patients. Cancer 2000; 89: 893–900.
3. Mauri D, Pentheroudakis G, Milousis A, Xilomenos A,
Panagoulopoulou E, Bristianou M, Zacharias G, Christidis D,
Mustou EA, Gkinosati A, Pavlidis N. Colorectal cancer screen-
ing awareness in European primary care. Cancer Detect Prev
2006; 30: 75–82.
4. Xilomenos A, Mauri D, Kamposioras K, Gkinosati A,
Zacharias G, Sidiropoulou V, Papadopoulos P, Chatzimicha
lis G, Golfinopoulos V, Peponi C, Pacmer PA. Colorectal
cancer screening awareness among physicians in Greece. BMC
Gastroenterol 2006; 6: 18–23.
5. Kamposioras K, Casazza G, Mauri D, Lakiotis V, Corti
novis I, Xilomenos A,Peponi C, Golfinopoulos V, Milousis A,
Kakaridis D, Zacharias G, Karathanasi I, Ferentinos G,
Proiskos A, Panhellenic Association For Continual Medical
Research P. Screening chest radiography: results from a Greek
cross-sectional survey. BMC Public Health 2006; 6: 113–20.
6. Proiskos A, Loukidou E, Kamposioras K, Bristianou M,
Zina V, Pliadi O, Karakatsanis A, Alexiou G, Gkougkoutsi A,
Mauri D. Screening chest radiography in primary care: an
underestimated belief. Eur J Gen Pract 2005; 11: 76–7.
7. Stermer T, Hodgson S, Kavalier F, Watts S, Jones R.
Patients’ and professionals’ opinions of services for people at
an increased risk of colorectal cancer: an exploratory qualitative
study. Fam Cancer 2004; 3: 49–53.
8. MacKie RM. Awareness, knowledge and attitudes to
basal cell carcinoma and actinic keratoses among the general
public within Europe. J Eur Acad Dermatol Venereol 2004;
18: 552–5.
9. Halpern AC, Hanson LJ. Awareness of, knowledge of
and attitudes to nonmelanoma skin cancer (NMSC) and ac-
tinic keratosis (AK) among physicians. Int J Dermatol 2004;
43: 638–42.
10. Mauri J, Mauri D, Pazarlis P, Altinoz H, Rivas
Flores FJ, Karentzou I. PC 3-component database for com-
munity based medical trials. A cost–effective solutions both
for voluntary associations and institutions of the “emerging
world”. Gazz Med It – Arch Sci Med 2004; 163: 189–94.
11. Mauri D, Pazarlis P, Mauri J, Altinoz H, Rivas
Flores FJ, Karentzou I. SESy-Europe: a multi-language da-
tabase dedicated to cancer screening monitoring. J Exp Clin
Cancer Res 2004; 23: 441-5.
12. European Cancer Health Indicator Project
http://www.tumori.net/eurochip/
Copyright © Experimental Oncology, 2006
|
| id | nasplib_isofts_kiev_ua-123456789-137577 |
| institution | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| issn | 1812-9269 |
| language | English |
| last_indexed | 2025-12-07T18:14:35Z |
| publishDate | 2006 |
| publisher | Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| record_format | dspace |
| spelling | Mauri, D. Kamposioras, K. Polyzos, N.P. Flores F.J. Rivas Altinoz, H. Chojnacka, M. Karentzou, I. Dambrosio, M. Colichi, C. Oxiuzova, T. Kanavoura, E. Sousa B.A.M. da Silva Alves de Ivanova, D. Mauri, J. Karampoiki, V. Maragkaki, A. Xilomenos, A. 2018-06-17T13:06:01Z 2018-06-17T13:06:01Z 2006 Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force / D. Mauri, K. Kamposioras, N.P. Polyzos, Flores F.J. Rivas, H. Altinoz, M. Chojnacka, I. Karentzou, M. Dambrosio, C. Colichi, T. Oxiuzova, E. Kanavoura, Sousa B.A.M. da Silva Alves de, D. Ivanova, J. Mauri, V. Karampoiki, A. Maragkaki, 
 A. Xilomenos // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 252-253. — Бібліогр.: 12 назв. — англ. 1812-9269 https://nasplib.isofts.kiev.ua/handle/123456789/137577 en Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України Experimental Oncology Letter to editor Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force Article published earlier |
| spellingShingle | Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force Mauri, D. Kamposioras, K. Polyzos, N.P. Flores F.J. Rivas Altinoz, H. Chojnacka, M. Karentzou, I. Dambrosio, M. Colichi, C. Oxiuzova, T. Kanavoura, E. Sousa B.A.M. da Silva Alves de Ivanova, D. Mauri, J. Karampoiki, V. Maragkaki, A. Xilomenos, A. Letter to editor |
| title | Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force |
| title_full | Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force |
| title_fullStr | Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force |
| title_full_unstemmed | Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force |
| title_short | Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force |
| title_sort | rethinking anticancer screening strategies saving lives at front line. results from sesy_europe task force |
| topic | Letter to editor |
| topic_facet | Letter to editor |
| url | https://nasplib.isofts.kiev.ua/handle/123456789/137577 |
| work_keys_str_mv | AT maurid rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT kamposiorask rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT polyzosnp rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT floresfjrivas rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT altinozh rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT chojnackam rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT karentzoui rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT dambrosiom rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT colichic rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT oxiuzovat rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT kanavourae rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT sousabamdasilvaalvesde rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT ivanovad rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT maurij rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT karampoikiv rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT maragkakia rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce AT xilomenosa rethinkinganticancerscreeningstrategiessavinglivesatfrontlineresultsfromsesyeuropetaskforce |